Novel monoamine reuptake inhibitors/mu opioid receptor agonists for the treatment of pain

被引：0
|
作者：
Ajello, Christopher W. [1 ]
Leister, Lara K. [1 ]
Sellitto, Ian F. [1 ]
Saeui, Christopher T. [1 ]
Chu, Guo Hua [1 ]
Graczyk, Thomas M. [2 ]
George, Randi S. [2 ]
Little, Patrick J. [2 ]
DeHaven, Robert N. [2 ]
Le Bourdonnec, Bertrand [1 ]
Dolle, Roland E. [1 ]
机构：
[1] Adolor Corp, Dept Chem, Exton, PA 19341 USA
[2] Adolor Corp, Dept Pharmacol, Exton, PA 19341 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2009年 / 238卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
90-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Mu opioid receptor in endometriosis: A potential novel target for the treatment in endometriosis-associated pain.
    Matsuzaki, S
    Canis, M
    Pouly, J
    Rabischong, B
    Botchorischvili, R
    Mage, G
    FERTILITY AND STERILITY, 2005, 84 : S122 - S122
  • [22] A Novel Pain Management Paradigm: Conformational Studies of the Mu-Opioid Receptor
    Poole, Elizabeth
    Iliff, Hadley
    Edwards, Brady
    Hurst, Dow
    Reggio, Patricia
    BIOPHYSICAL JOURNAL, 2009, 96 (03) : 339A - 339A
  • [23] Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects
    Paton, Kelly F.
    Atigari, Diana, V
    Kaska, Sophia
    Prisinzano, Thomas
    Kivell, Bronwyn M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2020, 375 (02): : 332 - 348
  • [24] A Role for Novel, Orally Available Mu-Opioid Agonists with Both Centrally and Peripherally Mediated Analgesia in the Treatment of Neuropathic Pain
    Webster, L.
    Gursahani, H.
    Ali, C.
    Choi, I
    Riggs, J.
    Gogas, K.
    Iverson, M.
    Medve, R.
    Odinecs, A.
    Eldon, M.
    Evans, J.
    Quach, P.
    Trinchero, P.
    Hennessey, M.
    Harrison, S.
    4TH INTERNATIONAL CONGRESS ON NEUROPATHIC PAIN, 2013, : 77 - 82
  • [25] β-Fluorofentanyls Are pH-Sensitive Mu Opioid Receptor Agonists
    Rosas, Ricardo, Jr.
    Huang, Xi-Ping
    Roth, Bryan L.
    Dockendorf, Chris
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (09): : 1353 - 1356
  • [26] Ligand-Dependent Reversal Kinetics of Mu Opioid Receptor Agonists by the Novel Antagonist, Methocinnamox
    Smith, Hudson R.
    Chavera, Teresa S.
    Berg, Kelly A.
    Clarke, William P.
    FASEB JOURNAL, 2022, 36
  • [27] Search for the "Ideal Analgesic" in Pain Treatment by Engineering the Mu-Opioid Receptor
    Tao, Pao-Luh
    Law, Ping-Yee
    Loh, Horace H.
    IUBMB LIFE, 2010, 62 (02) : 103 - 111
  • [28] Current and future nonstimulants in the treatment of pediatric ADHD: monoamine reuptake inhibitors, receptor modulators, and multimodal agents
    Cutler, Andrew J.
    Mattingly, Gregory W.
    Jain, Rakesh
    O'Neal, Welton
    CNS SPECTRUMS, 2022, 27 (02) : 199 - 207
  • [29] Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl
    Maguire, David R.
    France, Charles P.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 784 : 199 - 206
  • [30] Selective δ opioid receptor agonists for inflammatory and neuropathic pain
    Dondio, G
    Ronzoni, S
    Farina, C
    Graziani, D
    Parini, C
    Petrillo, P
    Giardina, GAM
    FARMACO, 2001, 56 (1-2): : 117 - 119
12345